Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Century Therapeutics Inc (NASDAQ: IPSC) was $0.82 for the day, down -3.45% from the previous closing price of $0.85. In other words, the price has decreased by -$3.45 from its previous closing price. On the day, 0.53 million shares were traded. IPSC stock price reached its highest trading level at $0.8888 during the session, while it also had its lowest trading level at $0.81.
Ratios:
Our analysis of IPSC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.39 and its Current Ratio is at 10.39. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.26.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 04 ’24 when Farid Adrienne sold 1,033 shares for $1.23 per share. The transaction valued at 1,267 led to the insider holds 135,130 shares of the business.
Carr Douglas sold 283 shares of IPSC for $347 on Nov 04 ’24. The SVP Finance & Operations now owns 317,147 shares after completing the transaction at $1.23 per share. On Nov 04 ’24, another insider, Farid Adrienne, who serves as the Officer of the company, bought 1,033 shares for $1.23 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IPSC now has a Market Capitalization of 69783296 and an Enterprise Value of -73732664. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.94 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at -27.471 whereas that against EBITDA is 0.625.
Stock Price History:
The Beta on a monthly basis for IPSC is 1.73, which has changed by -0.7967822 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, IPSC has reached a high of $5.51, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -28.09%, while the 200-Day Moving Average is calculated to be -57.74%.
Shares Statistics:
IPSC traded an average of 627.06K shares per day over the past three months and 567410 shares per day over the past ten days. A total of 84.76M shares are outstanding, with a floating share count of 34.81M. Insiders hold about 59.06% of the company’s shares, while institutions hold 31.01% stake in the company. Shares short for IPSC as of 1736899200 were 3024409 with a Short Ratio of 4.82, compared to 1734048000 on 2707165. Therefore, it implies a Short% of Shares Outstanding of 3024409 and a Short% of Float of 4.35.
